Pulmonary Vascular Disorders

Pulmonary vascular disorders encompass a spectrum of conditions affecting the blood vessels within the lungs, leading to impaired circulation, gas exchange abnormalities, and right heart strain. Common examples include pulmonary arterial hypertension, pulmonary embolism, chronic thromboembolic pulmonary hypertension, and vasculitides involving the pulmonary arteries. These disorders can arise from congenital anomalies, thrombotic events, autoimmune processes, or chronic lung diseases, each presenting unique challenges for diagnosis and management.

Clinical manifestations often include exertional breathlessness, fatigue, chest discomfort, and in advanced stages, syncope or signs of right heart failure. Evaluation begins with non-invasive imaging such as echocardiography to assess pulmonary pressures and right ventricular function, complemented by advanced modalities like CT pulmonary angiography or ventilation-perfusion scanning to detect vascular obstructions or structural abnormalities. Pulmonary function tests and biomarkers, including brain natriuretic peptide, assist in monitoring disease progression and therapeutic response.

Management strategies are tailored to the specific etiology. Pulmonary arterial hypertension may be treated with vasodilators, endothelin receptor antagonists, phosphodiesterase inhibitors, or prostacyclin analogs, whereas thromboembolic disorders require anticoagulation or, in select cases, surgical or catheter-directed interventions. Supportive therapies, including oxygen supplementation and exercise programs, help maintain functional capacity. Ongoing research is exploring targeted molecular therapies, regenerative approaches, and minimally invasive interventions to improve vascular remodeling and patient outcomes. By integrating precise diagnostics, individualized treatment plans, and supportive care, management of pulmonary vascular disorders aims to optimize circulatory function, mitigate complications, and enhance quality of life for affected individuals.